Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR

Feng Du, Chenyang Qiao, Xiaowei Li, Zhangqian Chen, Hao Liu, Shengda Wu, Zhaoyan Qiu, Meirui Qian, Dean Tian, Kaichun Wu,

Theranostics · 2019 · 52 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

: FOXK2 serves as a prognostic biomarker in CRC. Cetuximab can block the EGF-NF-κB-FOXK2-EGFR feedback loop and suppress CRC metastasis.

References

31